Question 1

What is the analyst consensus rating for MDGL?

Accepted Answer

The analyst consensus rating for MDGL is "Buy" based on 6 analyst recommendations.

Question 2

What is the average price target for MDGL?

Accepted Answer

The average 12-month price target for MDGL is $758.17, representing an upside of 55.6% from the current price of $487.32.

Question 3

What do analyst ratings mean?

Accepted Answer

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

Question 4

What is a price target?

Accepted Answer

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.

Date	Analyst	Firm	Action	Rating	Price Target
Jan 28, 2026	Eliana Merle	Barclays	Initiates	Buy	$964.00
Jan 20, 2026	Jonathan Wolleben	Citizens	Maintains	Buy	$527.00 → $745.00 +218.00 (41.4%)
Dec 19, 2025	Yasmeen Rahimi	Piper Sandler	Maintains	Buy	$540.00 → $900.00 +360.00 (66.7%)
Dec 11, 2025	William Woods	B Riley	Maintains	Strong Buy	$560.00 → $670.00 +110.00 (19.6%)
Nov 21, 2025	Andrew S. Fein	HC Wainwright	Maintains	Strong Buy	$568.00 → $620.00 +52.00 (9.2%)
Nov 20, 2025	Jay Olson	Oppenheimer	Maintains	Buy	$600.00 → $650.00 +50.00 (8.3%)

Madrigal Pharmaceuticals (MDGL) Stock Analyst Forecast

Analyst Consensus Rating

Consensus Rating

Average Price Target

Latest MDGL Analyst Ratings & Recommendations